MetLife Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $504K | Sell |
|
|||||
|
2024
Q4 | $457K | Buy |
|
|||||
|
2024
Q3 | $543K | Buy |
|
|||||
|
2024
Q2 | $177K | Sell |
|
|||||
|
2024
Q1 | $342K | Hold |
|
|||||
|
2023
Q4 | $304K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $244K | Hold |
|
|||||
|
2023
Q1 | $187K | Hold |
|
|||||
|
2022
Q4 | $260K | Hold |
|
|||||
|
2022
Q3 | $223K | Hold |
|
|||||
|
2022
Q2 | $168K | Hold |
|
|||||
|
2022
Q1 | $172K | Buy |
|
|||||
|
2021
Q4 | $130K | Hold |
|
|||||
|
2021
Q3 | $126K | Hold |
|
|||||
|
2021
Q2 | $154K | Hold |
|
|||||
|
2021
Q1 | $205K | Sell |
|
|||||
|
2020
Q4 | $217K | Hold |
|
|||||
|
2020
Q3 | $188K | Buy |
|
|||||
|
2020
Q2 | $229K | Buy |
|
|||||
|
2020
Q1 | $110K | Buy |
|